Scholar Rock Holding SRRK
NASDAQ SRRK
$55.43 -0.51 (-0.91%)
As of: Sep 4, 2026 · 2:21 PM EDT

Scholar Rock Holding (SRRK) Assets Average (2018 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Assets Average of $469.8 million for Q1 2026, up 6.46% year-over-year from $441.2 million in Q1 2025, and up 15.14% quarter-over-quarter from $408.0 million in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Assets Average (2018 - 2026) Analysis & Trends

Scholar Rock Holding's Assets Average history runs 9 years deep, the most recent figure standing at $469.8 million for Q1 2026.

  • In Q1 2026, Assets Average rose 6.46% year-over-year to $469.8 million; the TTM figure through Mar 2026 stood at $469.8 million (up 6.46% YoY), while the FY2025 annual figure was $439.6 million, up 11.86% from the prior year.
  • Assets Average for Q1 2026 stood at $469.8 million, up from $408.0 million in the prior quarter.
  • The five-year high for Assets Average was $469.8 million in Q1 2026, with the low at $203.0 million in Q3 2024.
  • The 5-year median for Assets Average is $336.4 million (2023), against an average of $337.2 million.
  • The sharpest annual moves came in 2023 and 2025: Assets Average plunged 34.24% in 2023, then surged 85.16% in 2025.
  • Scholar Rock Holding's Assets Average stood at $374.2 million in 2022, then slipped by 24.95% to $280.9 million in 2023, then grew by 16.44% to $327.0 million in 2024, then advanced by 24.76% to $408.0 million in 2025, then increased by 15.14% to $469.8 million in 2026.
  • Business Quant data shows SRRK's Assets Average at $469.8 million in Q1 2026, $408.0 million in Q4 2025, and $375.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn -
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 3.29 Bn
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.42 Bn 27.59 Bn - 19.82 Bn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 2.09 Bn
10 Scholar Rock Holding 7.23 Bn 7.23 Bn - 529.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 529.40 Mn
Mar 31, 2026 469.76 Mn
Dec 31, 2025 408.00 Mn
Sep 30, 2025 375.88 Mn
Jun 30, 2025 373.80 Mn
Mar 31, 2025 441.24 Mn
Dec 31, 2024 327.03 Mn
Sep 30, 2024 203.00 Mn
Jun 30, 2024 247.08 Mn
Mar 31, 2024 289.16 Mn
Dec 31, 2023 280.86 Mn
Sep 30, 2023 267.79 Mn
Jun 30, 2023 299.81 Mn
Mar 31, 2023 336.44 Mn
Dec 31, 2022 374.24 Mn
Sep 30, 2022 407.22 Mn
Jun 30, 2022 345.05 Mn
Mar 31, 2022 285.21 Mn
Dec 31, 2021 301.42 Mn
Sep 30, 2021 315.22 Mn